ArticleFrontiers in neurology2026
Ultrasound-guided stellate ganglion acupuncture for chronic insomnia disorder using fNIRS: study protocol for a randomized controlled trial.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic insomnia disorder (CID) is common and often impairs daytime functioning and quality of life. Although cognitive behavioral therapy for insomnia and hypnotic medication are widely used, their clinical use may be limited by accessibility, cost, adherence, and concerns about long-term adverse effects. Acupuncture is commonly used for CID, but conventional acupuncture alone may require a relatively long treatment course. Because sympathetic hyperarousal plays an important role in insomnia, the stellate ganglion (SG) may represent a useful therapeutic target. This trial aims to evaluate the clinical efficacy and potential neurofunctional mechanisms of ultrasound-guided SG acupuncture combined with conventional acupuncture in patients with CID. Methods/design: This single-center, parallel-group randomized controlled trial will enroll 80 patients with CID, who will be allocated in a 1:1 ratio to a treatment group or a control group. In addition, healthy controls will be recruited for baseline functional near-infrared spectroscopy (fNIRS) comparison only. Before fNIRS acquisition, healthy controls will undergo clinical screening and baseline assessments. The control group will receive conventional acupuncture, whereas the treatment group will receive ultrasound-guided SG acupuncture plus conventional acupuncture. Both groups will receive 12 treatment sessions over 4 weeks. Outcomes will be assessed at baseline, week 4, and week 8. The primary outcomes are the Insomnia Severity Index (ISI) and fNIRS data of brain function. Secondary outcomes include the Pittsburgh Sleep Quality Index (PSQI), Hamilton Anxiety Rating Scale (HAMA), and overall clinical efficacy. Discussion: This trial will determine whether ultrasound-guided SG acupuncture combined with conventional acupuncture provides additional benefit over conventional acupuncture alone for CID. It will also explore treatment-related changes in brain function by combining clinical scales with fNIRS assessment. The findings may provide more objective evidence for acupuncture-based treatment of CID and help clarify its neurofunctional basis. Clinical trial registration: https://itmctr.ccebtcm.org.cn/mgt/dashboard, ITMCTR2025000535.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.